Iradimed (IRMD) just unveiled an announcement.
IRADIMED CORPORATION, a medical device company, has announced its uplisting from the Nasdaq Capital Market to the Nasdaq Global Market, effective June 14, 2024. This move signifies the company’s compliance with higher financial and corporate governance standards required by the Nasdaq Global Market. Shareholders and investors can look forward to continued trading under the ticker “IRMD,” reflecting the company’s growth and potential for increased visibility in the financial markets.
For a thorough assessment of IRMD stock, go to TipRanks’ Stock Analysis page.
